Korean Circ J.  2021 Dec;51(12):1030-1032. 10.4070/kcj.2021.0351.

The Use of Diuretics on Atrial Septal Defect: To Use or Not to Use

• Jang SI

• KMID: 2523156
• DOI: http://doi.org/10.4070/kcj.2021.0351

Reference

1. Cockerham JT, Martin TC, Gutierrez FR, Hartmann AF Jr, Goldring D, Strauss AW. Spontaneous closure of secundum atrial septal defect in infants and young children. Am J Cardiol. 1983; 52:1267–1271. PMID: 6650415.

2. Radzik D, Davignon A, van Doesburg N, Fournier A, Marchand T, Ducharme G. Predictive factors for spontaneous closure of atrial septal defects diagnosed in the first 3 months of life. J Am Coll Cardiol. 1993; 22:851–853. PMID: 8354823.

3. Helgason H, Jonsdottir G. Spontaneous closure of atrial septal defects. Pediatr Cardiol. 1999; 20:195–199. PMID: 10089243.

4. McMahon CJ, Feltes TF, Fraley JK, et al. Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart. 2002; 87:256–259. PMID: 11847166.

5. Keane JF, Lock JE, Fyler DC. Nadas’ Pediatric Cardiology. 2nd ed. Philadelphia: Saunders Elsevier;2006.

6. Jalal Z, Hascoët S, Gronier C, et al. Long-term outcomes after percutaneous closure of ostium secundum atrial septal defect in the young: a nationwide cohort study. JACC Cardiovasc Interv. 2018; 11:795–804. PMID: 29673513.

7. Jung SY, Kim AY, Jung JW, Choi JY. Procedural, early and long-term outcomes after percutaneous closure of atrial septal defect: comparison between large and very large atrial septal defect groups. Korean Circ J. 2019; 49:975–986. PMID: 31165594.

8. Sharma B, Pinto R, Dalvi B. Transcatheter closure of atrial septal defect in symptomatic children weighing ≤10 kg: addressing unanswered issues from a decade of experience. Ann Pediatr Cardiol. 2020; 13:4–10. PMID: 32030029.

9. Lee LS, Kim GB, Lee WJ, et al. Association between the use of diuretics and size reduction in pediatrics atrial septal defect. Korean Circ J. 2021; 51:1017–1029.